Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5227-5235

  Perlaman, Harris ^a   Georgnas, Constantinos ^a,b   Pagliari, Lisa J ^a   Koch, Alisa E ^a   Haines III, Kenneth ^a   Pope, Richard M ^a,c  

^a Lakeside Division   (United States)

^b 251 Hellenic Airforce Vet Aff G   (Greece)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C OXIDASE; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME RELEASE; FIBROBLAST; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION; OSTEOARTHRITIS; PERMEABILITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0343091223     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5227     Document Type: Article

References (65)

1. Kelekar, A., and C. B. Thompson. 1998. Bcl-2 homology domains: the role of BH3 domain in apoptosis. Trends Cell Biol. 8:324.
2. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322.
3. Veis, D. J., C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229.
4. Kamada, S., A. Shimono, Y. Shinto, T. Tsujimura, T. Takahashi, T. Noda, Y. Kitamura, H. Kondoh, and Y. Tsujimoto. 1995. Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair pigmentation, and distorted small intestine. Cancer Res. 55:354.
5. Korsmeyer, S. J. 1999. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59:1693s.
6. Firestein, G. S. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 39:1781.
7. Hashimoto, S., R. L. Ochs, S. Komiya, and M. Lotz. 1998. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 41:1632.
8. Zamzami, N., C. Brenner, I. Marzo, S. A. Susin, and G. Kroemer. 1998. Sub-cellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16:2265.
9. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627.
10. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T.-I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
11. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132.
12. Marzo, I., C. Brenner, N. Zamzami, S. A. Susin, G. Beutner, D. Brdiczka, R. Remy, Z. Xie, J. C. Reed, and G. Kroemer. 1998. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. J. Exp. Med. 187:1261.
13. Cosulich, S. C., P. J. Savory, and P. R. Clarke. 1999. Bcl-2 regulates amplification of caspase activation by cytochrome c. Curr. Biol. 9:147.
14. Rosse, T., R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner. 1997. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391:496.
15. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405.
16. Rinkenberger, J. L., and S. J. Korsmeyer. 1997. Errors of homeostasis and de-regulated apoptosis. Curr. Opin. Genet. Dev. 7:589.
17. Kuida, K., T. F. Haydar, C. Kuan, Y. Gu, C. Taya, H. Karasuyama, M. S. Su, P. Rakic, and R. A. Flavell. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325.
18. Rao, L., and E. White. 1997. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr. Opin. Genet. Dev. 7:52.
19. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healy, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
20. Altman, R., G. Alarcon, D. Appelrouth, D. Bloch, D. Borenstein, K. Brandt, C. Brown, T. D. Cooke, W. Daniel, D. Feldman, et al. 1991. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34:505.
21. Colombel, M., C. A. Olsson, P. Y. Ng, and R. Buttyan. 1992. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 52:4313.
22. Pope, R. M., R. Lovis, S. Mungre, H. Perlman, A. E. Koch, and G. K. Haines III. 1999. C/EBPβ in rheumatoid arthritis: correlation with inflammation, not disease specificity. Clin. Immunol. 91:271.
23. Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90:772.
24. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, A. Walz, and R. M. Stricter. 1994. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94:1012.
25. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674.
26. Perlman, H., M. Sata, K. Krasinski, T. Dorai, R. Buttyan, and R. Walsh. 2000. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyper-plasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res. 45: 570.
27. Dorai, T., H. Perlman, K. Walsh, A. Shabsign, E. T. Goluboff, C. A. Olsson, and R. Buttyan. 1999. A recombinant defective adenovirus agent expressing anti-Bcl-2 ribozyme promotes apoptosis of Bcl-2 expressing human prostate cancer cells. Int. J. Cancer 82:846.
28. Perlman, H., M. Sata, A. Le Roux, T. Sedlak, D. Branellec, and K. Walsh. 1998. Bax-mediated cell death by the Gax homeoprotein requires mitogen-activation but is independent of cell cycle activity. EMBO J. 17:3576.
29. Darzynkiewicz, Z., G. Juan, X. Li, W. Gorczyca, T. Murakami, and F. Traganos. 1997. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1.
30. Walter, D. H., J. Haendeler, J. Galle, A. M. Zeiher, and S. Dimmeler. 1998. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome c from mitochondria. Circulation 98:1153.
31. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309.
32. Green, D. R. 1998. Apoptotic pathways: the roads to ruin. Cell 94:695.
33. Bossy-Wetzel, E., D. D. Newmeyer, and D. R. Green. 1998. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:37.
34. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43.
35. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:806.
36. Bossy-Wetzel, E., and D. R. Green. 1999. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem. 274:17484.
37. Susin, S. A., H. K. Lorenzo, N. Zamzami, I. Marzo, C. Brenner, N. Larochette, M. C. Prevost, P. M. Alzari, and G. Kroemer. 1999. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189:381.
38. Matsumoto, S., U. Muller-Ladner, R. E. Gay, K. Nishioka, and S. Gay. 1996. Ultrastructural demonstration of apoptosis. Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J. Rheum. 23:1345.
39. Ceponis, A., J. Hietanen, M. Tamulaitiene, G. Partsch, H. Patiala, and Y. T. Konttinen. 1999. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology 38:431.
40. Sugiyama, M., T. Tsukazaki, A. Yonekura, S. Matsuzaki, S. Yamashita, and K. Iwasaki. 1995. Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann. Rheum. Dis. 55:442.
41. Salmon, M., D. Scheel-Toellner, A. P. Huissoon, D. Pilling, N. Shamsadeen, H. Hyde, A. D. D'Angeac, P. A. Bacon, P. Emery, and A. N. Akbar. 1997. Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99:439.
42. Liang, H. Y., M. Jiang, H. M. Chen, and Y. C. Wang. 1996. Overexpression of proto-oncogene bcl-2 in rheumatoid synovium. Br. J. Rheumatol. 35:803.
43. Marok, R., P. G. Winyard, A. Coumbe, M. L. Kus, K. Gaffney, S. Blades, P. I. Mapp, C. J. Morris, D. R. Blake, C. Kaltschmidt, et al. 1996. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
44. Handel, M. L., L. B. McMorrow, and E. M. Gravallese. 1995. Nuclear factor-κB in rheumatoid synovium. Arthritis Rheum. 38:1762.
45. Han, Z., D. L. Boyle, A. M. Manning, and G. S. Firestein. 1998. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197.
46. Aupperle, K. R., B. L. Bennett, D. L. Boyle, P. P. Tak, A. M. Manning, and G. S. Firestein. 1999. NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes. J. Immunol. 163:427.
47. Wakisaka, S., N. Suzuki, Y. Takeba, Y. Shimoyama, H. Nagafuchi, M. Takeno, N. Saito, T. Yokoe, A. Kaneko, T. Asia, et al. 1998. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis. Clin. Exp. Immunol. 114:119.
48. Kawakawi, A., K. Eguchi, N. Matsuoka, M. Tsuboi, Y. Kawabe, T. Aoyagi, and S. Nakataki. 1996. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1. Arthritis Rheum. 39: 1267.
49. Nakayama, K., K. Nakayama, I. Negishi, K. Kuida, I. Sawa, and D. Y. Loh. 1994. Targeted disruption of bcl-2αβ in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91:3700.
50. Kroemer, G., B. Dallaporta, and R. Resche, M. 1998. The mitochondrial death/ life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619.
51. Sun, X.-M., M. MacFarlane, J. Zhuang, B. B. Wolf, D. R. Green, and G. M. Cohen. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:5053.
52. L. J. Biol. Chem. 274:2225.
53. Pastorino, J. G., S. T. Chen, M. Tafani, J. W. Snyder, and J. L. Farber. 1998. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273:7770.
54. Xiang, J., D. T. Chao, and S. J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559.
55. Jurgensmeier, J. M., Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, and J. C. Reed. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95:4997.
56. Shimizu, S., M. Narita, and Y. Tsujimoto. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483.
57. Atug, F., L. Turkeri, M. Ozyurek, and A. Akdas. 1998. Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. Int. Urol. Nephrol. 30:455.
58. Smolewski, P., H. Niewiadomska, J. Z. Blonski, T. Robak, and E. Krykowski. 1998. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease. Neoplasma 45:140.
59. Eid, H., M. Gulyas, L. Geczi, I. Bodrogi, E. Institoris, and M. Bak. 1998. Expression of bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1/Pgp. Cancer 83:331.
60. Colombel, M., F. Symmans, S. Gil, K. M. O'Toole, D. Chopin, M. Benson, C. A. Olsson, S. Korsmeyer, and R. Buttyan. 1993. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143:390.
61. Moul, J. W. 1999. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy. Eur. Urol. 35:399.
62. Mackey, T. J., A. Borkowski, P. Amin, S. C. Jacobs, and N. Kyprianou. 1998. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 52:1085.
63. Nakata, B., K. Muguruma, K. Hirakawa, Y. S. Chung, Y. Yamashita, T. Inoue, T. Matsuoka, N. Onoda, Y. Kato, and M. Sowa. 1998. Predictive value of Bcl-2 and Bax protein expression for chemotherapeutic effect in gastric cancer: a pilot study. Oncology 55:543.
64. Bincoletto, C., S T. Saad, E. S. da Silva, and M. L. Queiroz. 1999. Haematopoietic response and bcl-2 expression in patients with acute myeloid leukaemia. Eur. J. Haematol. 62:38.
65. Mulherin, D., O. Fitzgerald, and B. Bresnihan. 1996. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39:115.